Quick Takeaways
- Avraham Ben-Tzvi has 8 issuer positions tracked on this page.
- Estimated disclosed ownership value: $437,910.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Avraham Ben-Tzvi
- Location
- Efrat, Israel
- Summary
- The estimated net worth of Avraham Ben-Tzvi is at least $437,910 dollars as of 28 Apr 2026. Avraham Ben-Tzvi is the Director of MINIM, INC. and owns shares of FiEE, Inc. (FIEE) stock worth about $278.4K. Avraham Ben-Tzvi is the Director of OPGEN INC and owns shares of CapForce Inc. (CFOR) stock worth about $85K. Avraham Ben-Tzvi is the Director of Indaptus Therapeutics, Inc. and owns shares of Indaptus Therapeutics, Inc. (INDP) stock worth about $68.3K. Avraham Ben-Tzvi is the Director of Black Titan Corp and owns shares of Black Titan Corp (BTTC) stock worth about $5.3K. Avraham Ben-Tzvi is the Director of MAINZ BIOMED N.V. and owns shares of MAINZ BIOMED N.V. (QUCY) stock worth about $948.
- Signature
- /s/ Avraham Ben-Tzvi
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Avraham Ben-Tzvi and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: MINIM, INC. ($278,390).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Avraham Ben-Tzvi
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FIEE | MINIM, INC. | Director | $278,390 | 26 Sep 2024 | ||
| CFOR | OPGEN INC | Director | $85,000 | 11 Apr 2024 | ||
| INDP | Indaptus Therapeutics, Inc. | Director | $68,272 | 23 Dec 2025 | ||
| BTTC | Black Titan Corp | Director | $5,300 | 01 Oct 2025 | ||
| QUCY | MAINZ BIOMED N.V. | Director | $948 | 22 Apr 2026 | ||
| BGMS, BGMSP | Cyclacel Pharmaceuticals, Inc. | Director | $0 | 26 Feb 2025 | ||
| TTNP | TITAN PHARMACEUTICALS INC | Director | $0 | 01 Oct 2025 | ||
| YHC | LQR House Inc. | Director | 16 Oct 2024 |
Insider Transactions Reported by Avraham Ben-Tzvi:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.